市場調查報告書
商品編碼
920448

前列腺癌治療的全球市場預測(2019年∼2025年)

Global Prostate Cancer Therapeutics Market 2019-2025

出版日期: | 出版商: Orion Market Research Pvt Ltd | 英文 | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球前列腺癌治療市場,由於前列腺癌的發生率上升,堅實的研究開發的探求,津貼,及發現前列腺癌治療的替代方案的投資,而前景樂觀。前列腺癌是睪固酮依賴性的疾病,初期階段對藥和治療有反應,不過,後期對治療藥和其他治療方法有抗性。前列腺癌,有年齡、民族、家族病史及遺傳基因、過重或肥胖、IGF-1(成長因素等的胰島素)、輸精管切除,及前列腺的發炎等特定的原因。

本報告提供全球前列腺癌治療藥市場相關調查分析,市場概要,市場決策要素,市場區隔,競爭情形,各地區分析,主要企業等相關的系統性資訊。

目錄

第1章 報告概要

  • 調查方法與工具
  • 市場分析
    • 各市場區隔
    • 各地區

第2章 市場概要與考察

  • 報告的範圍
  • 分析師的考察和最新市場趨勢
    • 主要調查結果
    • 建議
    • 結論
  • 規則、規定

第3章 競爭環境

  • 企業佔有率分析
  • 主要策略分析
  • 主要企業分析
    • Sanofi S.A.
    • Astellas Pharma Inc.
    • Bayer AG
    • Johnson&Johnson Services,Inc.
    • AstraZeneca PLC

第4章 市場決策要素

  • 成長要素
  • 阻礙因素
  • 市場機會

第5章 市場區隔

  • 全球前列腺癌治療市場:各治療法
    • 荷爾蒙療法
    • 化療
    • 免疫療法
    • 放射線治療
    • 標靶治療

第6章 地區分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 其他
  • 其他地區

第7章 公司概要

  • Abbott Laboratories, Inc.
  • AbbVie, Inc.
  • Amgen, Inc.
  • Anixa Biosciences, Inc.
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • Bavarian Nordic A/S
  • Bayer AG
  • Bristol-Myers Squibb Co.
  • Decipher Biosciences, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Ferring B.V.
  • General Electric Co.
  • GlaxoSmithKline PLC
  • Ipsen Group
  • Johnson & Johnson Services, Inc.
  • MDNA Life Sciences, Inc.
  • Merck KGaA
  • miR Scientific, LLC
  • Myriad Genetics, Inc.
  • Nanostics Inc.
  • Novartis AG
  • Pfizer, Inc.
  • Sanofi S.A.
  • Siemens Healthcare AG
目錄
Product Code: OMR2020060

Prostate Cancer Therapeutics Market Size, Share & Trends Analysis Report, By Therapy (Hormonal Therapy, Chemotherapy, Immunotherapy, Radiation Therapy, and Targeted Therapy) and Forecast 2019-2025

The global prostate cancer therapeutics market has witnessed optimistic growth owing to the rising incidence rate of prostate cancer, robust R&D exploration and grants and investment for discovery of potential alternatives for prostate cancer treatment. Prostate cancer is an androgen-dependent disease that responds to medicine and treatment in the initial stages, however, in the later stages, it becomes resistant to therapies and other treatments. There are certain causes of prostate cancer which includes age, ethnicity, family history and genes, being overweight or obese, IGF-1 (Insulin such as growth factor), vasectomy, and inflammation of the prostate and others.

The US contributes highest in the prostate cancer treatment market owing to the significant prevalence of prostate cancer and the presence of well-developed healthcare infrastructure in the country. The rising adoption of minimally invasive surgeries is contributing to the demand for laparoscopic, brachytherapy, cryosurgical ablation and robotic radical prostatectomy for the treatment of prostate cancer. Other factors that are boosting the global prostate cancer therapeutics market includes R&D, rise in grants and funding, increasing adoption of personalized medicines, growing pharmaceutical industries and others. Further, successful clinical trials and FDA approval will influence the market growth in the near future.

North America and Europe have considerable contribution in the growth of the market followed by Asia-Pacific region. The key driving forces include rising incidence and prevalence of prostate cancer and adoption of innovative surgeries and treatment across the globe. Economies such as China, India, Japan, and South Korea have huge population of cancer patients. Technological advancement, innovation, and improved healthcare spending are anticipated to drive the growth of Asia-Pacific region. Improved standard of living, infrastructural development, and favorable government policies are some other factors that spur the regional growth of the market.

Some of the key players contributing significantly in the growth of prostate cancer therapeutics market include Sanofi S.A., Bayer AG, Astellas Pharma Inc., Merck KGaA, F. Hoffmann-La Roche Ltd., Johnson & Johnson Services, Inc., and AstraZeneca PLC. The market players are constantly focusing on product launch, R&D, partnerships and collaborations, and mergers and acquisitions.

Research Methodology

The market study of the global prostate cancer therapeutics market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity in our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market.
  • Authentic public databases such as the American Cancer Society, and the National Institute of Health.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalogue.

The report is intended for cancer diagnostics, treatment and therapies providers, cancer drug manufacturers, pharmaceutical companies, healthcare organization, existing companies, and new entrants, potential investors and venture capitalists, research organizations, and government agencies and regulatory bodies for overall market analysis and competitive analysis. The report provides in-depth analysis on market size, products offered by the company, and future market opportunity. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.

Market Segmentation:

1. Global Prostate Cancer Therapeutics Market Research and Analysis, By Therapy

The Report covers:

  • Comprehensive research methodology of the global prostate cancer therapeutics market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global prostate cancer therapeutics market.
  • Insights about market determinants which are stimulating the global prostate cancer therapeutics market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 1.2.3. Key Findings
    • 1.2.4. Recommendations
    • 1.2.5. Conclusion
  • 2.3. Rules & Regulations

3. Competitive Landscape

  • 3.1. Company Share Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
    • 3.3.1. Sanofi S.A.
      • 3.3.1.1. Overview
      • 3.3.1.2. Financial Analysis
      • 3.3.1.3. SWOT Analysis
      • 3.3.1.4. Recent Developments
    • 3.3.2. Astellas Pharma, Inc.
      • 3.3.2.1. Overview
      • 3.3.2.2. Financial Analysis
      • 3.3.2.3. SWOT Analysis
      • 3.3.2.4. Recent Developments
    • 3.3.3. Bayer AG
      • 3.3.3.1. Overview
      • 3.3.3.2. Financial Analysis
      • 3.3.3.3. SWOT Analysis
      • 3.3.3.4. Recent Developments
    • 3.3.4. Johnson & Johnson Services, Inc.
      • 3.3.4.1. Overview
      • 3.3.4.2. Financial Analysis
      • 3.3.4.3. SWOT Analysis
      • 3.3.4.4. Recent Developments
    • 3.3.5. AstraZeneca PLC
      • 3.3.5.1. Overview
      • 3.3.5.2. Financial Analysis
      • 3.3.5.3. SWOT Analysis
      • 3.3.5.4. Recent Developments

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Prostate Cancer Therapeutics Market by Therapy
    • 5.1.1. Hormonal Therapy
    • 5.1.2. Chemotherapy
    • 5.1.3. Immunotherapy
    • 5.1.4. Radiation Therapy
    • 5.1.5. Targeted Therapy

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Abbott Laboratories, Inc.
  • 7.2. AbbVie, Inc.
  • 7.3. Amgen, Inc.
  • 7.4. Anixa Biosciences, Inc.
  • 7.5. Astellas Pharma, Inc.
  • 7.6. AstraZeneca PLC
  • 7.7. Bavarian Nordic A/S
  • 7.8. Bayer AG
  • 7.9. Bristol-Myers Squibb Co.
  • 7.10. Decipher Biosciences, Inc.
  • 7.11. F. Hoffmann-La Roche Ltd.
  • 7.12. Ferring B.V.
  • 7.13. General Electric Co.
  • 7.14. GlaxoSmithKline PLC
  • 7.15. Ipsen Group
  • 7.16. Johnson & Johnson Services, Inc.
  • 7.17. MDNA Life Sciences, Inc.
  • 7.18. Merck KGaA
  • 7.19. miR Scientific, LLC
  • 7.20. Myriad Genetics, Inc.
  • 7.21. Nanostics Inc.
  • 7.22. Novartis AG
  • 7.23. Pfizer, Inc.
  • 7.24. Sanofi S.A.
  • 7.25. Siemens Healthcare AG

List of Tables

  • 1. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY THERAPY, 2018-2025 ($ MILLION)
  • 2. GLOBAL HORMONAL THERAPY FOR PROSTATE CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 3. GLOBAL CHEMOTHERAPY FOR PROSTATE CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 4. GLOBAL IMMUNOTHERAPY FOR PROSTATE CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 5. GLOBAL RADIATION THERAPY FOR PROSTATE CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 6. GLOBAL TARGETED THERAPY FOR PROSTATE CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 7. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025 ($ MILLION)
  • 8. NORTH AMERICAN PROSTATE CANCER THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 9. NORTH AMERICAN PROSTATE CANCER THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY THERAPY, 2018-2025 ($ MILLION)
  • 10. EUROPEAN PROSTATE CANCER THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 11. EUROPEAN PROSTATE CANCER THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY THERAPY, 2018-2025 ($ MILLION)
  • 12. ASIA-PACIFIC PROSTATE CANCER THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 13. ASIA-PACIFIC PROSTATE CANCER THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY THERAPY, 2018-2025 ($ MILLION)
  • 14. REST OF THE WORLD PROSTATE CANCER THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY THERAPY, 2018-2025 ($ MILLION)

List of Figures

  • 1. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET SHARE BY THERAPY, 2018 VS 2025 (%)
  • 2. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)
  • 3. US PROSTATE CANCER THERAPEUTICS SIZE, 2018-2025 ($ MILLION)
  • 4. CANADA PROSTATE CANCER THERAPEUTICS MARKET SIZE, 2018-2025 ($ MILLION)
  • 5. UK PROSTATE CANCER THERAPEUTICS MARKET SIZE, 2018-2025 ($ MILLION)
  • 6. FRANCE PROSTATE CANCER THERAPEUTICS MARKET SIZE, 2018-2025 ($ MILLION)
  • 7. GERMANY PROSTATE CANCER THERAPEUTICS MARKET SIZE, 2018-2025 ($ MILLION)
  • 8. ITALY PROSTATE CANCER THERAPEUTICS MARKET SIZE, 2018-2025 ($ MILLION)
  • 9. SPAIN PROSTATE CANCER THERAPEUTICS MARKET SIZE, 2018-2025 ($ MILLION)
  • 10. ROE PROSTATE CANCER THERAPEUTICS MARKET SIZE, 2018-2025 ($ MILLION)
  • 11. INDIA PROSTATE CANCER THERAPEUTICS MARKET SIZE, 2018-2025 ($ MILLION)
  • 12. CHINA PROSTATE CANCER THERAPEUTICS MARKET SIZE, 2018-2025 ($ MILLION)
  • 13. JAPAN PROSTATE CANCER THERAPEUTICS MARKET SIZE, 2018-2025 ($ MILLION)
  • 14. REST OF ASIA-PACIFIC PROSTATE CANCER THERAPEUTICS MARKET SIZE, 2018-2025 ($ MILLION)
  • 15. REST OF THE WORLD PROSTATE CANCER THERAPEUTICS MARKET SIZE, 2018-2025 ($ MILLION)